Cureus
Clinical Significance of the Identification of an Anti-M (IgG) Alloantibody in Pregnancy
By Alla Iashchuk and Ricardo Sardo.
Abstract
Anti-M is usually a naturally occurring, cold-reactive immunoglobulin M (IgM) antibody and is commonly regarded as clinically insignificant.An immunoglobulin G (IgG) component, however, can cross the placenta and has rarely been associated with hemolytic disease of the fetus and newborn (HDFN), including hyporegenerative fetal or neonatal anemia.A 42-year-old woman (G4P2A2) undergoing preconception evaluation had a positive indirect antiglobulin test (IAT) with initially inconclusive antibody identification.Reference immunohematology testing identified anti-M reactivity at 4°C.After dithiothreitol (DTT) treatment, an immunoglobulin G component was confirmed at a titer of 1:2.The direct antiglobulin test (DAT) remained negative, and there was no evidence of maternal hemolysis.Her partner was M antigen positive, indicating that a future fetus could inherit the target antigen.This case shows that detailed characterization of an apparently cold-reactive anti-M antibody can materially change preconception counseling and pregnancy planning.Low titer alone should not replace consideration of antibody class, thermal amplitude, obstetric history, paternal or fetal antigen status, and coordinated follow-up by transfusion medicine and maternal-fetal medicine teams.




